(Q33326045)

English

Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice (English)

1 reference

Europe PubMed Central

25 July 2017

0 references

prostate neoplasm

1 reference

based on heuristic

inferred from title

Johanna M Tuomela

object named as

Johanna M Tuomela

1

0 references

author name string

Maija P Valta

2

1 reference

Europe PubMed Central

25 July 2017

Kalervo Väänänen

3

1 reference

Europe PubMed Central

25 July 2017

Pirkko L Härkönen

4

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

28 March 2008

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

8

1 reference

Europe PubMed Central

25 July 2017

81

1 reference

Europe PubMed Central

25 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

28 March 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-81

0 references

Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Bone loss and fracture risk associated with cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Clinical features of metastatic bone disease and risk of skeletal morbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Hypoxia-inducible factor-1 in human breast and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Emerging anti-cancer molecular mechanisms of aminobisphosphonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Alendronate inhibits proliferation and invasion of human epidermoid carcinoma cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Expression signature of the mouse prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

The role of bisphosphonates in the treatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Laparoscopic radical prostatectomy with the Heilbronn technique: oncological results in the first 500 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Focus on lymphangiogenesis in tumor metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Genetically defined mouse models that mimic natural aspects of human prostate cancer development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

The potential role of bisphosphonates in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Actions of bisphosphonates in animal models of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

LYVE-1, the lymphatic system and tumor lymphangiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Bisphosphonates induce breast cancer cell death in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Angiogenesis in cancer and other diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

21 June 2018

Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Extraosseous uptake of metastatic lymph nodes of ureteral cancer on 99Tcm hydroxymethylene diphosphonate bone scintigraphy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-81

21 January 2018

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

31 October 2018

Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

31 October 2018

Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

31 October 2018

Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294135

31 October 2018

Prostate cancer epidemiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extraosseous localization of 99mTc-MDP in ganglioneuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of metastasis by the human prostate cancer cell line PC-3 in athymic nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic model for human prostate cancer using orthotopic implantation in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18371232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-81

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

release_ywshvhsvavhmzht5ys25td4lui

1 reference

https://api.fatcat.wiki/v0/release/ywshvhsvavhmzht5ys25td4lui

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33326045&oldid=1979684966"